Recommendations

Listen to what Berty de Koning has to say about Dr. Boers-Doets's Approach

"I developed 90% of the side effects that can come along with panitumumab. With help of the TARGET strategy, I was able to relieve the side effects within 48 hours every time. Even the nail of this finger was not removed at the emergency room because it was treated effectively with vinegar bathes supported with antibiotics.

Simple, effective, and fast!"

Therefore, I warmly applaud all research aimed at alleviating the side effects of cancer treatment.

First-hand experience has taught me that not only the disease itself but its side effects, too, can have a huge impact.

It is regrettable that, as a result, some patients do not complete the treatment as planned.

We can’t stay without side effects research.

All patients should have access to Christine's TARGET strategy!

- Berty de Koning, patient, Leiderdorp, The Netherlands"

Praise for Dr. Christine's TARGET System book

A Tool for a Broad Audience!

“This book makes evidence-based research and years of practical experience available to a broad audience."

Erik van Muilekom, MANP

Antoni van Leeuwenhoek (AVL) Hospital Netherlands Cancer Institute (NKI) Amsterdam, The Netherlands

& Past-president of EONS

Practical Steps!

"This book provides healthcare professionals with practical steps to approach mucocutaneous adverse events systematically and effectively, improving therapy outcomes and quality of life.”

Joel B. Epstein, DMD

Division of Otolaryngology & Head & Neck Surgery, City of Hope, Duarte, CA, USA

Follow the System!

"I encourage all practitioners who care for patients treated with targeted cancer therapies to follow The Target System, as it will undoubtedly improve the care & quality of life of people living with cancer.“

Mario E. Lacouture, MD

Chief Dermatology Division

Department of Medicine

Perlmutter Cancer Center at NYU Langone Hospital—Long Island,

New York, USA

Success Stories
Patients tell about Dr. Christine's side effect approach

MR. STIPDONK:

"I suffered calluses my entire life, but the calluses grew exponentially large while on regorafenib. I was not able to walk anymore or enjoy my hobby. Christine explained how to apply the TARGET strategy on the calluses and how I could get rid of them. I followed the strategy, and you can see the result: I am still on regorafenib AND can enjoy my hobby again. The TARGET strategy led to hemorrhoid cream. Amazing what hemorrhoid cream on the hand palms and foot soles can do!"

MS. DE KONING:

"I developed 90% of the side effects that can accompany panitumumab. With the TARGET strategy's help, I could relieve the side effects within 48 hours every time. Even the nail of this finger was not removed at the emergency room because it was treated effectively with vinegar baths supported by antibiotics.

Simple, effective, and fast!"

MR. SCHULTZE:

"My mother was diagnosed with NSCLC in September 2012 and treated with gefitinib. She wanted to stop treatment due to extremely painful nail folds.

Through Christine’s simple but effective measures, resulting from the TARGET strategy, my mother was able to continue treatment for 5 more years!"

Wouter Jacobs, MD
pulmonologist Martini Hospital, The Netherlands

pulmonologists & medical oncologists use the strategy,
nurses use the strategy,
patients use the strategy…

… discover this practical approach yourself

LEARN ABOUT THE TARGET STRATEGY

What key opinion leaders say about Dr. Boers-Doets's TARGET Strategy:

It's a Key Tool!

“The six steps in The Target Strategy are very helpful in a busy clinical setting or during research protocols."

Mario E. Lacouture, MD

Chief Dermatology Division

Department of Medicine

Perlmutter Cancer Center at NYU Langone Hospital—Long Island,

New York, USA

Promotes Continuation of Therapy!

"Chris is very dedicated to improving patients' quality of life by finding solutions for every patient."

Joel B. Epstein, DMD

Division of Otolaryngology & Head & Neck Surgery, City of Hope, Duarte, CA, USA

It's a Unique, Practical Tool!

"The six steps can be very helpful to manage complicated side effects, and it is more likely that the entire extent is explored and treated in the right way.”

Erik van Muilekom, MANP

Antoni van Leeuwenhoek (AVL) Hospital Netherlands Cancer Institute (NKI) Amsterdam, The Netherlands

& Past-president of EONS

Start Today!

Wemke Tuinier, MANP

LEARN ABOUT THE TARGET STRATEGY

Here is what physicians say about Dr. Christine's approach:

René-Jean Bensadoun, MD

Professor in Radiation Oncology,

Oncologue-Radiothérapeute, Gérant au Centre de Haute Energie, Nice, France.

“Chris is a very dedicated person and a great scientist, full of positive energy, initiative, and enthusiasm.”

Dr. Frans Krouwels, MD

Pumonologist, Spaarne Hospital
Hoofddorp, The Netherlands

"Christine’s experiences, expertise & assistance provided me with a solid grounding in the evidence guiding the approaches & interventions she described and demonstrated, and practical considerations to enable practitioners to be successful."

Ferdinand Haslbauer, MD

Oncology, Salzkammergut Klinikum Vöcklabruck, Austria

"Christine's recommendations were a real eye opener!

Despite of several existing guidelines of how to handle these adverse events, Christine´s HHES method (Hit Hard Early & Short) during her lecture, emphasized on correct dosing of different corticosteroids, their equivalence dosages, as well as their anti-inflammatory properties and ary duration of treatment."

I'm now prepared for
Future Medications to come

"In August 2018, Christine held a two-day course on adverse event management at our Breast Cancer Unit in preparation for implementing an outpatient clinic. Medical oncologists, breast and oncology nurses, pharmacists, and patient advocates participated.

The interdisciplinary training Christine provided was very effective and very much appreciated. She triggered participants to be actively involved. Her systematic adverse event and cancer medication approach is easy to apply in daily practice.

After the training, she was available for online consultation, which allowed us to test what we learned and to continue to be updated.

The method we learned can easily be applied to future medications. We will definitely continue to work with CancerMed and be ready to recommend her training to other institutions."

Prof. Olivia Pagani | Medical Oncologist
Breast Unit and Institute of Oncology of Southern Switzerland, CSSI - Centro di Senologia della Svizzera Italiana, Ospedale Regionale di Lugano, Italiano, Ospedale Regionale di Bellinzona e Valli, S. Giovanni

Here is what nurses say about Dr. Christine's approach:

Marlies Kuystermans, MANP

Nurse Specialist Intensive Care
Amphia Hospital
Breda, The Netherlands

“Christine quickly and very knowledgeably answered all my questions about practical matters and any adverse events with the use of therapy, so I can properly inform and advise my patients.”

DGKP Karin Pennetzdorfer & Bianca Schedler

DGKP's Bianca Schedler & Karin Pennetzdorfer Oncology, Salzkammergut Klinikum Vöcklabruck, Austria

"We were most impressed by the way Christine communicates with her patients. Her ASK method has become a fixed part of communications with our patients. Due to the insights, we significantly improved our work!"

Nele Debbaut, oncology nurse medical oncology / radiation-therapy. Ghent University Hospital, Belgium

"Finally, a simplification and the distinction between side effects from chemo and targeted therapy were real eye-openers. The distinction between mucositis and stomatitis and between hand-foot syndrome and hand-foot skin reaction was enlightening. It actually makes a lot of sense if you look at it that way."

Here is what Professors say about Dr. Christine's scientific work:

“Christine is an enthusiastic and talented practitioner in the area of Supportive Care in Cancer, particularly in the field of Targeted Cancer Therapy. She is doing very important work for the benefit of cancer patients.”

Professor Dorothy Keefe, MD

Clinical Ambassador, Transforming Health,

South Australia

“Christine is a creative, hard-working, inspiring researcher in supportive care in hemato-oncology. She succeeded in establishing and developing her own research domain with clear future perspectives.”

Hans Nortier, MD

Emeritus Professor in Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands

Here is what Pharmaceutical representatives say about Dr. Christine's approach:

“Christine is a highly recommended person who can teach and advise you in the medical science world. She knows her patients well and gives them good advice, just as she gives to healthcare professionals. She also gives good advice on the oncology products they use for their patients.”

Dea Brouwer

Product Specialist Oncology at Roche Netherlands

"I know Christine as a very scientific person who is attacked by the vicissitudes of (oncological) patients.

I worked with her in the area of continuing education. The continuing educations of Christine are professional and well organized. Here is much room for the listener to pose questions. Great partner!"

Johan Van Kampen

Therapeutic Area Manager Hematology at Amgen Netherlands